Get the Stockscreener App
6.21
0.47%
-0.0293
After Hours:
6.20
-0.010
-0.16%
Immucell Corp stock is traded at $6.21, with a volume of 11,645.
It is down -0.47% in the last 24 hours and down -1.58% over the past month.
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
See More
Previous Close:
$6.2393
Open:
$6.17
24h Volume:
11,645
Relative Volume:
0.81
Market Cap:
$56.17M
Revenue:
$23.84M
Net Income/Loss:
$-3.81M
P/E Ratio:
-12.42
EPS:
-0.5
Net Cash Flow:
$-713.00K
1W Performance:
-0.48%
1M Performance:
-1.58%
6M Performance:
+17.39%
1Y Performance:
+73.46%
1-Day Range:
$5.90
$6.24
1-Week Range:
$5.89
$6.6452
52-Week Range:
$3.38
$7.60
Immucell Corp Stock (ICCC) Company Profile
Name
Immucell Corp
Sector
Industry
Phone
(207) 878-2770
Address
56 EVERGREEN DR, PORTLAND, ME
Compare ICCC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICCC
Immucell Corp
|
6.21 | 56.44M | 23.84M | -3.81M | -713.00K | -0.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Immucell Corp Stock (ICCC) Latest News
What MACD signals say about ImmuCell CorporationEarnings Risk Report & Daily Oversold Stock Bounce Ideas - newser.com
Will ImmuCell Corporation stock rally after Fed decisionsProfit Target & Fast Gain Swing Trade Alerts - newser.com
Is ImmuCell Corporation stock positioned for long term growthWeekly Market Summary & Reliable Breakout Stock Forecasts - newser.com
Will ImmuCell Corporation bounce back from current supportPortfolio Gains Summary & Fast Exit Strategy with Risk Control - newser.com
Multi asset correlation models including ImmuCell CorporationWeekly Trade Report & Risk Controlled Swing Alerts - newser.com
Why ImmuCell Corporation stock is seen as undervaluedWeekly Stock Recap & Real-Time Volume Analysis - newser.com
How to forecast ImmuCell Corporation trends using time seriesJuly 2025 Analyst Calls & Free Accurate Trade Setup Notifications - newser.com
ImmuCell Corporation (ICCC) Stock Price, News, Quote & History - Yahoo! Finance Canada
ImmuCell Corp. Experiences Revision in Its Stock Evaluation Amid Mixed Performance Metrics - Markets Mojo
How high can ImmuCell Corporation stock goAnalyst Downgrade & Consistent Profit Trade Alerts - newser.com
Can technical indicators confirm ImmuCell Corporation’s reversalJuly 2025 Selloffs & Free High Return Stock Watch Alerts - newser.com
Custom strategy builders for tracking ImmuCell CorporationBond Market & Fast Entry and Exit Trade Plans - newser.com
Can machine learning forecast ImmuCell Corporation recoveryJuly 2025 Trade Ideas & Daily Stock Momentum Reports - newser.com
Weiss Ratings Reaffirms "Hold (C-)" Rating for ImmuCell (NASDAQ:ICCC) - MarketBeat
Can ImmuCell Corporation stock deliver surprise earnings beatEarnings Beat & Free Community Consensus Stock Picks - newser.com
Immucell reports preliminary Q3 revenue $5.5M vs. $6M last year - MSN
ImmuCell Corporation: At A Major Inflection Point (ICCC) - Seeking Alpha
Signal Recap: Does ImmuCell Corporation stock trade at a discount to peersMarket Growth Review & Daily Stock Momentum Reports - Trung tâm Dự báo KTTV quốc gia
Will ImmuCell Corporation stock gain from lower inflationSwing Trade & Expert Curated Trade Setups - newser.com
Why ImmuCell Corporation stock is trending among retail tradersAnalyst Upgrade & Accurate Entry/Exit Alerts - Trung tâm Dự báo KTTV quốc gia
Aug Breakouts: Can ImmuCell Corporation (IUL) stock resist broad market declinesInflation Watch & Verified Swing Trading Watchlists - Trung tâm Dự báo KTTV quốc gia
How to track smart money flows in ImmuCell CorporationOil Prices & Reliable Entry Point Trade Alerts - newser.com
Is ImmuCell Corporation stock reversal real or fake2025 Historical Comparison & Accurate Intraday Trade Tips - newser.com
Will ImmuCell Corporation continue its uptrendPortfolio Risk Summary & Daily Entry Point Alerts - newser.com
Live market analysis of ImmuCell CorporationJuly 2025 Catalysts & Weekly Chart Analysis and Guides - newser.com
ImmuCell (NASDAQ:ICCC) Stock Passes Above 200-Day Moving AverageHere's What Happened - MarketBeat
Detecting price anomalies in ImmuCell Corporation with AI2025 Technical Overview & Fast Entry High Yield Stock Tips - newser.com
The Zacks Analyst Blog Highlights SAP, Novartis, Philip Morris International, ImmuCell and ClearOne - sharewise.com
ImmuCell's (ICCC) "Hold (C-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Top Stock Reports for SAP, Novartis & Philip Morris - Zacks Investment Research
ImmuCell Corporation Reports Preliminary Third Quarter 2025 Sales Results - Quiver Quantitative
Immucell Corp Stock (ICCC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):